4.6 Article

Epidemiology and Management of ST-Segment-Elevation Myocardial Infarction in Patients With COVID-19: A Report From the American Heart Association COVID-19 Cardiovascular Disease Registry

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit The INSPIRATION Randomized Clinical Trial

Parham Sadeghipour et al.

Summary: This study compared the effect of intermediate-dose and standard prophylactic anticoagulation on a composite outcome among COVID-19 patients admitted to the ICU. The results showed no significant difference between the two groups in terms of thrombotic events, ECMO therapy, or mortality within 30 days. The study does not recommend routine use of intermediate-dose prophylactic anticoagulation in unselected ICU patients with COVID-19.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Medicine, General & Internal

Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial

Renato D. Lopes et al.

Summary: In hospitalized COVID-19 patients with elevated D-dimer concentration, in-hospital therapeutic anticoagulation with rivaroxaban or enoxaparin followed by rivaroxaban to day 30 did not improve clinical outcomes and increased bleeding compared with prophylactic anticoagulation. Therapeutic-dose rivaroxaban and other direct oral anticoagulants should be avoided in these patients without an evidence-based indication for oral anticoagulation.

LANCET (2021)

Article Medicine, General & Internal

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

Ewan C. Goligher et al.

Summary: In critically ill patients with Covid-19, initial therapeutic-dose anticoagulation did not result in improved survival rates or fewer days requiring cardiovascular or respiratory organ support compared to usual-care pharmacologic thromboprophylaxis.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Editorial Material Cardiac & Cardiovascular Systems

Temporary Emergency Guidance to STEMI Systems of Care During the COVID-19 Pandemic AHA's Mission: Lifeline

Alice K. Jacobs

CIRCULATION (2020)

Letter Cardiac & Cardiovascular Systems

ST-Elevation Myocardial Infarction in Patients With COVID-19 Clinical and Angiographic Outcomes

Giulio G. Stefanini et al.

CIRCULATION (2020)

Letter Cardiac & Cardiovascular Systems

Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong Kong, China

Chor-Cheung Frankie Tam et al.

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2020)

Article Cardiac & Cardiovascular Systems

Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic From the ACC's Interventional Council and SCAI

Frederick G. P. Welt et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Letter Medicine, General & Internal

Endothelial cell infection and endotheliitis in COVID-19

Zsuzsanna Varga et al.

LANCET (2020)

Letter Medicine, General & Internal

ST-Segment Elevation in Patients with Covid-19-A Case Series

Sripal Bangalore et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Cardiac & Cardiovascular Systems

Characteristics and Outcomes in Patients Presenting With COVID-19 and ST-Segment Elevation Myocardial Infarction

Anas Hamadeh et al.

AMERICAN JOURNAL OF CARDIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

American Heart Association COVID-19 CVD Registry Powered by Get With The Guidelines

Heather M. Alger et al.

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2020)

Article Cardiac & Cardiovascular Systems

High Thrombus Burden in Patients With COVID-19 Presenting With ST-Segment Elevation Myocardial Infarction

Fizzah A. Choudry et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Editorial Material Cardiac & Cardiovascular Systems

Severe COVID-19 Is a Microvascular Disease

Charles J. Lowenstein et al.

CIRCULATION (2020)

Article Cardiac & Cardiovascular Systems

Management and Outcomes of Patients With STEMI During the COVID-19 Pandemic in China

Dingcheng Xiang et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)